Interbalkan Medical Center

What Interbalkan Medical Center does

Interbalkan Medical Center is a private hospital located in Thessaloniki, Greece, that operates a Department of Interventional Radiology and Oncology under the direction of Dr. Ioannis Dedes (Ioannis Dedes / Ιωάννης Δέδες). The department specializes in minimally invasive, non-surgical treatment of primary and metastatic tumors of the liver, kidneys, and lungs, serving oncology patients across Greece and the Balkans. Its service portfolio encompasses transarterial chemoembolization (classical TACE, DEB-TACE, biodegradable particle variants), Yttrium-90 radioembolization delivered in collaboration with the hospital's Nuclear Medicine department, CT-guided percutaneous ablation (microwave, radiofrequency, cryoablation), superselective embolization for benign and malignant conditions, angioplasty with stent placement, and percutaneous abscess and biliary drainage. Procedures are performed under digital angiography and CT guidance, with single-day hospitalization typical, and the practice draws on more than 20 years of clinical experience and over 2,000 chemoembolization procedures performed by the department director.

The hospital's revenue model is fee-for-service medical care delivered within a private hospital setting; it is contracted with EOPYY (the Greek national health insurance provider) and also accepts self-paying and international patients. Distribution is direct-to-patient at the single Thessaloniki facility, with patient acquisition driven by physician referrals from oncologists and gastroenterologists, conference-based thought leadership (WCIO, CIRSE, European and Hellenic congresses), a trilingual website (Greek, English, Russian), an online medical consultation service, and peer endorsements from international cancer centers including Memorial Sloan-Kettering. Dr. Dedes is a founding member of the Society of Interventional Oncology (SIO), and the practice regularly presents at global interventional oncology conferences, establishing referral pull from across the Balkans and beyond.

Strategically, the department's positioning rests almost entirely on the clinical reputation of a single named interventional radiologist, with no disclosed corporate ownership structure, parent company, subsidiaries, funding rounds, M&A activity, or patent portfolio in the input data. Operational signals (active website, near-zero serious complication rates reported since 2000, ongoing patient testimonials, and conference participation) indicate a stable, operating practice rather than a growth-stage or venture-backed entity.

Name

Interbalkan Medical Center

Legal name

Interbalkan Medical Center (Ιατρικό Διαβαλκανικό Θεσσαλονίκης)

Website

https://dedesioannis.gr

Company type

Private

Operating status

Operating

Headcount range

101–250 employees

Short description

Interbalkan Medical Center operates a Department of Interventional Radiology and Oncology in Thessaloniki, Greece, providing minimally invasive TACE, Y-90 radioembolization, ablation, and embolization treatments to oncology patients from Greece and the Balkans, directed by Dr. Ioannis Dedes.

Ownership category

akta.pro rank

Product category

Interventional Oncology and Interventional Radiology Services

NAICS

Offices of Physicians (62111), Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

akta.pro secondary industries

Interventional Radiology & Image-Guided Therapy Systems (HLAHABAG), Radiation Oncology (HLAKAFAC), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

Keywords

• Interventional radiology
• Interventional oncology
• Tumor chemoembolization
• Tumor ablation
• Minimally invasive oncology

Headquarters

HQ city

Thessaloniki

HQ country

Greece

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Services Revenue: Revenue generated from interventional oncology and radiology procedures performed at Medical Inter-Balkan Center. Services include chemoembolization, radioembolization, ablation therapies, embolization procedures, and ancillary diagnostic/treatment services. Single-day hospitalization typical for most procedures.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

The Department of Interventional Radiology at Medical Inter-Balkan Center provides minimally invasive, image-guided treatments for primary and metastatic tumors of the liver, kidneys, and lungs, as well as select benign conditions. Core offerings include transarterial chemoembolization (TACE, including DEB-TACE), Yttrium-90 radioembolization, and CT-guided percutaneous ablation (microwave, radiofrequency, cryoablation), supplemented by embolization, angioplasty/stenting, abscess drainage, and online consultation services.

Product overview

The medical practice offers a unified portfolio of interventional oncology and radiology treatments centered at Interbalkan Medical Center in Thessaloniki, Greece. The core offering comprises endovascular procedures (chemoembolization, radioembolization, embolization) and transdermal ablation therapies (RF, microwave, cryoablation) for treating primary and metastatic tumors of the liver, kidneys, and lungs. Supporting treatments include angioplasty/stenting, abscess drainage, and online consultation services. The practice specializes in minimally invasive, non-surgical cancer treatments with over 20 years of experience and more than 2,000 chemoembolization procedures performed.

Differentiator

Problem solved

Functional benefit

Products and services

• Chemoembolization (TACE)
• Radioembolization (Y-90)
• Tumor Ablation
• Embolization Procedures
• Angioplasty and Stenting
• Abscess Drainage

Quantifiable outcome

• Success rates for chemoembolizations higher than international standards
• +2 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Society of Interventional Oncology (SIO)coreStrategic or Co-development PartnerDr. Ioannis Dedes is a founding member of the Global Society of Interventional Oncology (SIO), actively participating in the development and advancement of the field of interventional oncology internationally.
• Nuclear Medicine Department (Interbalkan Medical Center)coreStrategic or Co-development PartnerCollaboration with Nuclear Medicine department for radioembolization procedures (Y-90), which requires combined expertise for safe and effective treatment delivery.
• Memorial Sloan-Kettering Cancer CenterminorStrategic or Co-development PartnerProfessional collaboration and exchange with renowned cancer center. Dr. Dedes has participated in sessions and has professional relationships with physicians from the center including Prof. C.T. Sofocleous.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• European Institute of Oncology (IEO), Milan: Privately-endowed Italian cancer center offering interventional oncology for liver, lung, and kidney tumors. Comparable because it combines a private-hospital operating model with high-end oncologic specialization similar to Interbalkan's positioning.
• MD Anderson Cancer Center: Top-ranked U.S. cancer center with one of the largest Interventional Oncology programs globally, performing TACE, radioembolization, and ablation across liver, kidney, and lung tumors. Closest direct functional peer given similar modality breadth and tumor-type coverage.
• Universitätsklinikum Frankfurt (Goethe University): Frankfurt University Hospital's Institute for Interventional Radiology and Oncology, where Dr. Dedes completed subspecialty training. Directly comparable as a German academic reference site whose protocols and case mix underpin the Interbalkan practice.
• Memorial Sloan Kettering Cancer Center: World-leading U.S. cancer center with a dedicated Interventional Radiology Service performing TACE, Y-90 radioembolization, and tumor ablation. Explicitly comparable because Dr. Dedes has peer-level professional ties to MSK's interventional oncology faculty (e.g., C.T. Sofocleous).
• Charité – Universitätsmedizin Berlin (Interventional Radiology): Major German university hospital with a high-volume interventional radiology department offering TACE, Y-90, and percutaneous ablation. Comparable as a European tertiary academic reference center with which Dr. Dedes shares clinical lineage via Frankfurt University training.

Regional players

• Iatropolis – Mediterranean Healthcare Group: Greek private healthcare group operating oncology and diagnostic imaging services. Comparable as a domestic Greek private-sector competitor for insured and self-pay oncology referrals.
• Hygeia Group (Diagnostic & Therapeutic Center of Athens): Largest Greek private hospital group, headquartered in Athens, with oncology and interventional radiology coverage. Comparable as a Greek private-sector competitor for oncology referrals but primarily Athens-based rather than Thessaloniki.

Broad incumbents

• Cleveland Clinic: Large U.S. multi-specialty health system with interventional oncology and interventional radiology programs (TAE/TACE, Y-90, ablation). Comparable because a Cleveland Clinic surgeon (Andreas Tzakis) provided a peer testimonial on Dr. Dedes' chemoembolization outcomes, signaling parallel practice scope.
• Johns Hopkins Interventional Radiology Center: U.S. academic interventional radiology division with significant TACE, Y-90, and ablation volume. Comparable as a leading tertiary referral center for the same interventional oncology indications Interbalkan treats.
• Mount Sinai Interventional Radiology: U.S. academic medical center with a high-volume interventional oncology service (chemoembolization, radioembolization, ablation). Comparable as a multi-modality IO reference center at academic scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/interbalkan-medical-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Interbalkan Medical Center